SCHEMBL1338963

SCHEMBL1338963

CCn1nccc1-c1ccc2[nH]c3c(cc(-c4ccc(Cl)cc4Cl)c(=O)n3C)c2c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABL1 P00519 1/20 0.38
▸ MARS1 P56192 1/20 0.38
▸ IDH1 O75874 1/20 0.35
▸ CNR1 P21554 8/20 0.35
▸ CNR2 P34972 8/20 0.35
▸ HAVCR2 Q8TDQ0 1/20 0.35
▸ HSD11B1 P28845 1/20 0.34
▸ F2RL3 Q96RI0 1/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ EGFR P00533 1/20 0.33
▸ ALOX5 P09917 1/20 0.33
▸ ADORA3 P0DMS8 1/20 0.33
▸ GABRA1 P14867 1/20 0.33
▸ ADRA2C P18825 1/20 0.33
▸ MAPK3 P27361 1/20 0.33
▸ OPRL1 P41146 1/20 0.33
▸ SLC6A3 Q01959 1/20 0.33
▸ SLC18A2 Q05940 1/20 0.33
▸ MAPK14 Q16539 1/20 0.33
▸ TMEM97 Q5BJF2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1339397 0.82 MARS1 (0.39) ABL1MARS1CNR1CNR2HSD11B1
SCHEMBL1338048 0.81 NOTUM (0.38) CNR1CNR2HSD11B1F2RL3ALDH1A1
SCHEMBL1338440 0.80 MAP2 (0.45) IDH1CNR1CNR2HSD11B1F2RL3
SCHEMBL1338675 0.79 CNR1 (0.37) CNR1CNR2HSD11B1F2RL3EGFR
SCHEMBL1339352 0.78 TLR8 (0.39) CNR1CNR2HSD11B1F2RL3EGFR
SCHEMBL1339158 0.78 MARS1 (0.36) MARS1CNR1CNR2HSD11B1ALDH1A1
SCHEMBL3567753 0.77 HTR1A (0.40) CNR1CNR2HSD11B1F2RL3ALDH1A1
SCHEMBL1339374 0.77 CNR1 (0.38) CNR1CNR2HSD11B1F2RL3ALDH1A1
SCHEMBL1338742 0.77 F2RL3 (0.37) CNR1CNR2HSD11B1F2RL3ALDH1A1
SCHEMBL958804 0.77 F2RL3 (0.46) CNR1CNR2HSD11B1F2RL3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8063061-B2 6-(2-amino-1,3-thiazol-4-yl)-3-(2,4-dichlorophenyl)-1-methyl-1,9-dihydro-2H-pyrido[2,3-b]indol-2-one; affinity for GABAA-receptor-associated omega modulatory sites SANOFI-AVENTIS (FR) 2011-11-22 — — US disclosed
US-20080262020-A1 6-Heteroarylpyridoindolone Derivatives, Their Preparation and Therapeutic Use Thereof SANOFI-AVENTIS (FR) 2008-10-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080262020-A1 6-Heteroarylpyridoindolone Derivatives, Their Preparation and Therapeutic Use Thereof CYP11B2, CYP11B1, CYP2D6 ABL1 91/4885MARS1 2786/4885IDH1 142/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback